Cost of cancer care: issues and implications.
Medical technology is increasingly costly in most fields of clinical medicine. Oncology has not been spared from issues related to cost, in part resulting from the tremendous scientific progress that has lead to new tools for diagnosis, treatment, and follow-up of our patients. The increasing cost of health care in general (and cancer care in particular) raises complex questions related to its effects on our economy and the citizens of our society. This article reviews the macroeconomic principles and individual behaviors that govern medical spending, and examines how cost disproportionately affects various populations. Our overall goal is to frame debate about health policy concerns that influence the clinical practice of oncology.
Meropol
Neal J
NJ
Division of Medical Science, Fox Chase Cancer Center, Philadelphia, PA 19111, USA. neal.meropol@fccc.edu
Schulman
Kevin A
KA
D020811:Biomedical Technology / Q000639:trends; D004470:Economics, Medical / Q000639:trends; D017048:Health Care Costs / Q000639:trends*; D005102:Health Expenditures / Q000639:trends*; D006291:Health Policy / Q000191:economics; D006801:Humans; D008495:Medical Oncology / Q000191:economics* / Q000639:trends; D009369:Neoplasms / Q000191:economics* / Q000517:prevention & control / Q000628:therapy*; D014481:United States